Completed
Levocetirizine + Capecitabine + Bevacizumab for Patients With Refractory Colorectal Cancer
NCT01722162
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +8 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States